Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telatinib + Chemotherapy in Advanced Gastric Cancer
NCT00952497Phase 2Completed
- Sponsor
- ACT Biotech Inc
- Start
- Jun 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of telatinib in gastric cancer (GC), sponsored by ACT Biotech Inc. Started Jun 2009; status: completed.
02
Drugs
telatinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00952497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952497.